LONDON, Dec 13: There is little evidence to back the use of a cannabis extract spray made by GW Pharmaceuticals for spasticity in patients with multiple sclerosis, according to a medical journal review published on Thursday. GW Pharma said the report in the Drug and Therapeutics Bulletin (DTB), a British Medical Journal publication, gave ‘a misleading view of the drug’ and contained a number of errors. (agencies)
Follow our WhatsApp channel